She added: “Most of our patients are severe and most of them are leaving at six days, so that tells us duration of therapy doesn’t have to be 10 days. We have very few that went out to 10 days, maybe three,” she stated.

Reached by STAT, Mullane confirmed the authenticity of the footage however declined to remark additional.

Requested concerning the data, Eric Topol, director of the Scripps Analysis Translational Institute, described them as “encouraging.”

“The severely hit patients are at such high-risk of fatality. So if it’s true that many of the 113 patients were in this category and were discharged, it’s another positive signal that the drug has efficacy,” he stated, including that it is going to be vital to see extra data from randomized managed research.